The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Koreshkova K.M.

Bashkir State Medical University, Russia

Khismatullina Z.R.

Bashkir State Medical University, Russia

Quality of life in psoriatic arthritis: review of selected assessment methods and their results

Authors:

Koreshkova K.M., Khismatullina Z.R.

More about the authors

Read: 1702 times


To cite this article:

Koreshkova KM, Khismatullina ZR. Quality of life in psoriatic arthritis: review of selected assessment methods and their results. Russian Journal of Clinical Dermatology and Venereology. 2022;21(1):15‑20. (In Russ.)
https://doi.org/10.17116/klinderma20222101115

Recommended articles:
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Pathogenetic inte­rrelations of hypo­gonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23

References:

  1. Orbai AM, de Wit M, Mease P. International patient andphysician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673-680.  https://doi.org/10.1136/annrheumdis-2016-210242
  2. Strand V, Sharp V, Koenig AS. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis. 2012;71:1143-1150. https://doi.org/10.1136/annrheumdis-2011-200387
  3. Ana MO, Maarten de W, Philip JM, Duffin KC, Musaab E, William T, Willemina C, Oliver F, Dafna DG, Niti G, Laure G, Pil H, Ying YL, Chris L, Vibeke S, Désirée MH, Bev S, Robin Ch, Laura C, Lihi Er, Neil Mc, Umut K, Ingrid S, Alexis O. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. The Journal of Rheumatology. 2017;44(1):1522-1528. https://doi.org/10.3899/jrheum.160904
  4. Boers M, Kirwan JR, Wells G. Developing core outcomemeasurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014;67:745-753.  https://doi.org/10.1016/j.jclinepi.2013.11.013
  5. Kalyoncu U, Ogdie A, Campbell W. Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open. 2016;2:e000217. https://doi.org/10.1136/rmdopen-2015-000217
  6. De Wit M, Kvien T, Gossec L. Patient participation as an integral part of patient reported outcomes development guarantees the representativeness of the patient voice — a case-study from the field of rheumatology. RMD Open. 2015;1(1):e000129. https://doi.org/10.1136/rmdopen-2015-000129
  7. Di Carlo M, Becciolini A, Lato V. The 12-item psoriatic arthritis impact of disease questionnaire: construct validity, reliability, and interpretability in a clinical setting. J Rheumatol. 2017;44:279-285.  https://doi.org/10.3899/jrheum.160924
  8. Tania G, Laure G. Quality of life in psoriatic arthritis. Expert Review of Clinical Immunology. 2018;14(5):405-417.  https://doi.org/10.1080/1744666X.2018.1468252
  9. Gossec L, De Wit M, Kiltz U. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012-1019. https://doi.org/10.1136/annrheumdis-2014-205207
  10. Philip JM, Woolley JM, Bojena B, Brian CW, Denise RG, Amitabh S. Minimally Important Difference of Health Assessment Questionnaire in Psoriatic Arthritis: Relating Thresholds of Improvement in Functional Ability to Patient-rated Importance and Satisfaction. The Journal of Rheumatology. 2011;38(11):2461-2465. https://doi.org/10.3899/jrheum.110546
  11. Korotaeva TV, Korsakova YuL. Psoriatic arthritis: classification, clinical presentation, diagnosis, treatment. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(1):60-69. (In Russ.). https://doi.org/10.14412/1995-4484-2018-60-69
  12. Priscilla CHW, Ying-Ying L, Edmund K Li, Lai-Shan T. Measuring Disease Activity in Psoriatic Arthritis. International Journal of Rheumatology. 2012(5): 839425. https://doi.org/10.1155/2012/839425
  13. Filimonova OG, Simonova OV, Leushina EA, Chuprakov PG. Estimate of basic therapy for quality of life and the psychoemotional status in patients with psoriatic arthritis. Siberian Medical Journal. 2011;1:64. (In Russ.).
  14. Mease PJ. Measures of psoriatic arthritis: tender and swollen jointassessment, psoriasis area and severity index (PASI), nail psoriasis severity index (NAPSI), modified nail psoriasis severity index(mNAPSI), Mander/Newcastle enthesitis index (MEI), Leeds enthesitis index (LEI), Spondyloarthritis Research Consortium of Canada(SPARCC), Maastricht ankylosing spondylitis enthesis score (MASES),Leeds dactylitis index (LDI), patient global for psoriatic arthritis, dermatology life quality index (DLQI), psoriatic arthritis quality of life(PsAQOL), functional assessment of chronic illness therapy-fatigue(FACIT-F), psoriatic arthritis response criteria (PsARC), psoriatic arthritis joint activity index (PsAJAI), disease activity in psoriatic arthritis(DAPSA), and composite psoriatic disease activity index (CPDAI). Arthritis Care Res (Hoboken). 2011;63(11):64-85.  https://doi.org/10.1002/acr.20577
  15. Taylor WJ. Impact of psoriatic arthritis on the patient: through the lens of the WHO international classification of functioning, health, and disability. Curr Rheumatol Rep. 2012;14:369-374.  https://doi.org/10.1007/s11926-012-0263-5
  16. Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology (Oxford). 2012;51:275-283.  https://doi.org/10.1093/rheumatology/ker216
  17. Tillett W, Shaddick G, Askari A. Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. Rheumatology (Oxford). 2015;54:157-162.  https://doi.org/10.1093/rheumatology/keu264
  18. Kennedy M, Papneja A, Thavaneswaran A. Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis. Clin Exp Rheumatol. 2014;32:342-348. 
  19. Walsh JA, McFadden ML, Morgan MD. Work productivity lossand fatigue in psoriatic arthritis. J Rheumatol. 2014;41:1670-1674. https://doi.org/10.3899/jrheum.140259
  20. Emily McD, Renise A, Lihi E, Vinod Ch, Cheryl FR, Arane Th, Gladman DD. Depression and Anxiety in Psoriatic Disease: Prevalence and Associated Factors. The Journal of Rheumatology. 2014;41(5):887-896.  https://doi.org/10.3899/jrheum.130797
  21. Freire M, Rodriguez J, Moller I. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics [Spanish]. Reumatol Clin. 2011;7:20-26.  https://doi.org/10.1016/j.reuma.2010.03.003
  22. Michelsen B, Kristianslund EK, Sexton J. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76:1906-1910. https://doi.org/10.1136/annrheumdis-2017-211284
  23. McDonough E, Ayearst R, Eder L. Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol. 2014;41:887-896.  https://doi.org/10.3899/jrheum.130797
  24. Kotsis K, Voulgari PV, Tsifetaki N. Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res. 2012;64:1593-1601. https://doi.org/10.1002/acr.21725
  25. Putrik P, Ramiro S, Hifinger M. In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study. Ann Rheum Dis. 2016;75:715-720.  https://doi.org/10.1136/annrheumdis-2015-207738

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.